
Critical Needs. Immediate Action.
SERB is a fast-growing global specialty pharma company designed to address rare and urgent conditions by delivering life-saving medicines when time and complexity leave no room for failure.
We operate end-to-end across 100+ countries, ensuring 70+ essential medicines for rare diseases, emergency care, and medical countermeasures reach patients and clinicians with urgency – wherever and whenever they are needed. Shaped over the past 25 years by an entrepreneurial, disruptive spirit, SERB combines the focus and agility of a biotech with the scale, reach, and reliability of a global pharmaceutical company — always grounded in medical purpose, not corporate convention.
Our 600+ employees are driven by three core values:
Guided by a clear ambition and a relentless focus on patients, SERB continues to expand through selective, innovative acquisitions, launching new treatments and entering new geographies. Across every step — from integration to delivery — our people act with passion, ownership, and determination to ensure life-saving medicines become available to patients who need them, worldwide.
The Director, Medical Strategy – Rare Emergency Medicine will serve as a key member of the US Medical team, responsible for developing and executing the integrated medical strategy for the company's Emergency Medicine portfolio. This strategic leader will collaborate cross-functionally with Clinical Development, Commercial, Regulatory, Market Access, and other key stakeholders to ensure successful development, launch, and lifecycle management of innovative therapies addressing high unmet medical needs.
The above duties and responsibilities are not an exhaustive list, and you may be required to undertake any other reasonable duties compatible with your experience and competencies. This description may be varied from time to time to reflect changing business requirements.
Serb Pharmaceuticals is an equal opportunity employer. We offer competitive compensation & benefit packages, challenging opportunities and a culture of working together in a supportive way built on our strong foundation of values.

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for rare diseases, rare emergencies, and CBRN preparedness.
For over 30 years we have consistently supplied emergency medicines, medical countermeasures, and the world’s leading portfolio of antidotes.
SERB began in France as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research), but today our direct commercial presence spans US, Europe, and the Middle East. Healthcare providers in over 100 countries rely on us for a broad range of essential medicines delivered via healthcare systems, first responders, emergency preparedness agencies, and non-profit organisations. Our proven ability to acquire, develop, manufacture, launch and commercialize specialist medicines allows us to meet critical medical needs with urgency.
By expanding our reach through selective acquisitions and entering new markets, we’re not just supplying medicine; we’re improving the standard of care for more patients around the world.
Improving patients’ quality of life and offering hope is what motivates and inspires us.